Microbial Infections and Wound Healing: Medicinal-Chemistry and Technological Based Approaches
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: closed (30 October 2023) | Viewed by 13991
Special Issue Editors
Interests: drug delivery; peptide drugs; neurodegenerative disorders; antimicrobial drug development
Special Issues, Collections and Topics in MDPI journals
Interests: drug delivery systems; CNS drug delivery; neurodegenerative disorders
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Wound infections represent one of the major clinical challenges responsible for high-level morbidity and mortality. Moreover, damaged tissues are more vulnerable to microbial infections, which induce alterations and may delay the wound healing process. In this regard, the ineffectiveness in wound management leads to a great social and economic impact on patient quality of life. Fortunately, in recent years, scientific communities have become open to new and attractive perspectives for the future of wound healing. Currently, efforts are focused on the development of innovative therapeutic strategies regarding both novel drug candidates and drug delivery systems for treating microbial infections and acute/chronic wounds. This Special Issue draws attention to the up-to-date findings and advanced therapeutic advances as potential approaches useful to implement the scientific knowledge in this field. For this purpose, we are encouraging scientists to present their original or review articles. We will be grateful to receive your manuscripts, and it will be a pleasure for us to collect them in this Special Issue.
Dr. Ivana Cacciatore
Dr. Lisa Marinelli
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antimicrobials
- drug delivery systems
- natural anti-bacterials
- peptides
- polymers
- small molecules
- therapeutic strategies
- wound healing